Skip to main content
All lobbying filings

INNOVATIVE FEDERAL STRATEGIES, LLC

Lobbying for ACURX PHARMACEUTICALS, INC. · biopharmaceutical company

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $30,000.00 income · posted Apr 20, 2026

Official filing document

 Lobbying activity 1
Budget/Appropriations

H.R.____/S.____, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2027, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem